In clinical trials of ADHD, weight loss occurred in: 3% to 4% of adults who took Vyvanse 9% of children who took Vyvanse 0% to 1% of adults and children who took a placebo (treatment containing no active drug) After 4 weeks of treatment, the average weight loss in people who took Vyvanse was: 2.8 pounds (lb) to 4.3 lb (1.3 kilograms [kg] to 2 kg) in adults 2.7 lb to 4.8 lb (1.2 kg to 2.2 kg) in children ages 13 to 17 years 0.9 lb to 2.5 lb (0.4 kg to 1.1 kg) in children ages 6 to 12 years The amount of weight lost depended on dose, with more weight loss seen in people who took higher doses of Vyvanse
1 ottobre 2019 [citato 5 giugno 2024];257:7748
The top concern is the lack of research on the effectiveness or safety of microdosing the drugs (or using GLP-1s, period) in people with normal weight and blood sugar
May 13, 2026: New Jersey-Based Litigations Advancing While much of the attention is on the Ozempic MDLs, don't forget that many other cases are also active in New Jersey state court
The method for injecting a GLP-1 is mostly the same, regardless of whether youre injecting into the thigh, abdomen, or upper arm